Irays Medtech Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 10-01-2025
- Paid Up Capital ₹ 0.40 M
as on 10-01-2025
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.35 Cr
as on 10-01-2025
- Revenue 133.34%
(FY 2022)
- Profit 17.34%
(FY 2022)
- Ebitda 0.79%
(FY 2022)
- Net Worth 27.09%
(FY 2022)
- Total Assets 8.04%
(FY 2022)
About Irays Medtech Solutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹2.35 Cr.
Ashwini Sharma and Rishi Dev serve as directors at the Company.
- CIN/LLPIN
U74999HR2011PTC042251
- Company No.
042251
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Irays Medtech Solutions Private Limited offer?
Irays Medtech Solutions Private Limited offers a wide range of products and services, including MRI Machine, Hitachi MRI Machine, Surgical & ICU Equipments, ICU Equipments, Dialysis Machine, Ventilator, ICU Ventilator, Drager Ventilators, Patient Monitoring System, Contec Patient Monitor.
Who are the key members and board of directors at Irays Medtech Solutions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwini Sharma  | Director | 01-Mar-2011 | Current |
| Rishi Dev | Director | 05-Apr-2017 | Current |
Financial Performance of Irays Medtech Solutions.
Irays Medtech Solutions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 133.34% increase. The company also saw a substantial improvement in profitability, with a 17.34% increase in profit. The company's net worth Soared by an impressive increase of 27.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Irays Medtech Solutions?
Unlock access to Irays Medtech Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Feb 2023 | ₹2.35 Cr | Open |
How Many Employees Work at Irays Medtech Solutions?
Unlock and access historical data on people associated with Irays Medtech Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Irays Medtech Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Irays Medtech Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
